Literature DB >> 8418272

FDG-PET in oncology: there's more to it than looking at pictures.

A J Fischman, N M Alpert.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8418272

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  13 in total

1.  Prediction of pathology and survival by FDG PET in gliomas.

Authors:  M V Padma; S Said; M Jacobs; D R Hwang; K Dunigan; M Satter; B Christian; J Ruppert; T Bernstein; G Kraus; J C Mantil
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

2.  Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.

Authors:  V Arena; A Skanjeti; R Casoni; A Douroukas; E Pelosi
Journal:  Radiol Med       Date:  2008-07-10       Impact factor: 3.469

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 4.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

Review 5.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

6.  Usefulness of additional delayed regional F-18 Fluorodeoxy-Glucose Positron Emission Tomography in the lymph node staging of Non-Small Cell Lung Cancer patients.

Authors:  Young So; June-Key Chung; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

7.  Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.

Authors:  Katja Ott; Wolfgang A Weber; Ulrich Fink; Hermann Helmberger; Karen Becker; Hubert J Stein; James Müller; Markus Schwaiger; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

8.  FDG-PET for predicting the prognosis of malignant lymphoma.

Authors:  J Okada; H Oonishi; K Yoshikawa; J Itami; K Uno; K Imaseki; N Arimizu
Journal:  Ann Nucl Med       Date:  1994-08       Impact factor: 2.668

Review 9.  When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?

Authors:  Gang Cheng; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

10.  Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.

Authors:  U Lassen; G Daugaard; A Eigtved; L Højgaard; K Damgaard; M Rørth
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-09       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.